Paxlovid 5 days clinical trials

OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial

This study is looking at better ways to treat COVID-19 in people with weakened immune systems. It compares a standard antiviral treatment (Paxlovid) with a longer course, and with a combination of Paxlovid and another medicine (Veklury).